Burlingame, CA, United States of America

Neekesh Vijay Dharia

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neekesh Vijay Dharia. Retrieved from https://idiyas.com/inventor/neekesh-vijay-dharia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neekesh Vijay Dharia: Innovator in Cancer Treatment

Introduction

Neekesh Vijay Dharia is a prominent inventor based in Burlingame, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development efforts. His work focuses on combination therapies that aim to improve patient outcomes in oncology.

Latest Patents

Neekesh holds a patent for the treatment of cancer using combination therapies comprising GDC-6036 and GDC-0077. This patent outlines methods of using these therapies to effectively treat cancer, showcasing his commitment to advancing medical science.

Career Highlights

Neekesh is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His role at Genentech allows him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to cancer research.

Collaborations

Some of Neekesh's notable coworkers include Mark Merchant and Jennifer Lee Schutzman. Their collaborative efforts contribute to the innovative environment at Genentech, fostering advancements in cancer treatment.

Conclusion

Neekesh Vijay Dharia is a dedicated inventor whose work in cancer treatment exemplifies the impact of innovative therapies in medicine. His contributions continue to inspire advancements in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…